Portage Biotech Stock (NASDAQ:PRTG)


ForecastOwnershipFinancialsChart

Previous Close

$5.51

52W Range

$2.10 - $58.60

50D Avg

$4.56

200D Avg

$9.15

Market Cap

$5.74M

Avg Vol (3M)

$1.78M

Beta

96.71

Div Yield

-

PRTG Company Profile


Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

VG

Employees

7

IPO Date

Jan 02, 2002

Website

PRTG Performance


PRTG Financial Summary


Mar 23Mar 22Mar 21
Revenue---
Operating Income$-16.57M$-15.59M$-12.44M
Net Income$-104.61M$-19.17M$-17.19M
EBITDA$-16.62M$-15.65M$-14.19M
Basic EPS$-6.49$-1.47$-1.47
Diluted EPS$-6.49$-1.47$-1.47

Fiscal year ends in Mar 23 | Currency in USD

Peer Comparison


TickerCompany
FREQKorro Bio, Inc.
CUECue Biopharma, Inc.
XFORX4 Pharmaceuticals, Inc.
ARVNArvinas, Inc.
VECTVectivBio Holding AG
DBTXDecibel Therapeutics, Inc.
BPMCBlueprint Medicines Corporation
DAWNDay One Biopharmaceuticals, Inc.
EWTXEdgewise Therapeutics, Inc.
AVTEAerovate Therapeutics, Inc.
FENCFennec Pharmaceuticals Inc.
JANXJanux Therapeutics, Inc.
INZYInozyme Pharma, Inc.
KROSKeros Therapeutics, Inc.
HRMYHarmony Biosciences Holdings, Inc.
ABOSAcumen Pharmaceuticals, Inc.
ANEBAnebulo Pharmaceuticals, Inc.
KRTXKaruna Therapeutics, Inc.
ELYMEliem Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals, Inc.